COVID-19 Infection and Vaccination: Understanding the Prothrombotic Risk

Joining us today to discuss COVID-19 infection and vaccination and understanding what the prothrombotic risk is, Damon E. Houghton, M.D., M.S., associate professor of medicine and vascular medicine specialist in the department of cardiovascular medicine at Mayo Clinic in Rochester, Minnesota. Tune in to learn more about the prothrombotic risk in patients with COVID-19 infection and vaccination.

Specific topics discussed:
• What have we learned about the risk for thrombosis associated with COVID-19 infections?
• Recognizing the increased risk of thrombosis in some patients, what is the role of anti-thrombotic
medications for prevention?
• In April of 2021, the CDC and FDA paused administration of the Janssen (J&J) vaccination
temporarily due to strange cases of thrombosis and thrombocytopenia, what do we now know
about COVID-19 vaccinations and this adverse reaction?

From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi

Visit Mayo Clinic: https://mayocl.in/2COVmlm

Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on Twitter: https://twitter.com/MayoClinic